171 related articles for article (PubMed ID: 36630746)
21. A novel case of concurrent occurrence of demyelinating-polyneuropathy-causing PMP22 duplication and SOX10 gene mutation producing severe hypertrophic neuropathy.
Matsuda N; Ootsuki K; Kobayashi S; Nemoto A; Kubo H; Usami SI; Kanani K
BMC Neurol; 2021 Jun; 21(1):243. PubMed ID: 34171997
[TBL] [Abstract][Full Text] [Related]
22. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
Hanemann CO; Müller HW
Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
[TBL] [Abstract][Full Text] [Related]
23. Low affinity NGF receptor expression in CMT1A nerve biopsies of different disease stages.
Hanemann CO; Gabreëls-Fasten AA; Müller HW; Stoll G
Brain; 1996 Oct; 119 ( Pt 5)():1461-9. PubMed ID: 8931571
[TBL] [Abstract][Full Text] [Related]
24. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
[TBL] [Abstract][Full Text] [Related]
25. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
26. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
[TBL] [Abstract][Full Text] [Related]
27. Generation of one induced pluripotent stem cell line JUCGRMi004-A from a Charcot-Marie-Tooth disease type 1A (CMT1A) patient with PMP22 duplication.
Liu X; Ishikawa KI; Hattori N; Akamatsu W
Stem Cell Res; 2024 Jun; 77():103401. PubMed ID: 38537501
[TBL] [Abstract][Full Text] [Related]
28. Clinical implications of peripheral myelin protein 22 for nerve compression and neural regeneration: a review.
Hui-Chou HG; Hashemi SS; Hoke A; Dellon AL
J Reconstr Microsurg; 2011 Jan; 27(1):67-74. PubMed ID: 20976668
[TBL] [Abstract][Full Text] [Related]
29. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
30. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
31. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
Naef R; Suter U
Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
[TBL] [Abstract][Full Text] [Related]
32. Biochemical characterization of protein quality control mechanisms during disease progression in the C22 mouse model of CMT1A.
Chittoor VG; Sooyeon L; Rangaraju S; Nicks JR; Schmidt JT; Madorsky I; Narvaez DC; Notterpek L
ASN Neuro; 2013 Dec; 5(5):e00128. PubMed ID: 24175617
[TBL] [Abstract][Full Text] [Related]
33. Induced myelination and demyelination in a conditional mouse model of Charcot-Marie-Tooth disease type 1A.
Perea J; Robertson A; Tolmachova T; Muddle J; King RH; Ponsford S; Thomas PK; Huxley C
Hum Mol Genet; 2001 May; 10(10):1007-18. PubMed ID: 11331611
[TBL] [Abstract][Full Text] [Related]
34. Comparison of a new pmp22 transgenic mouse line with other mouse models and human patients with CMT1A.
Robertson AM; Perea J; McGuigan A; King RH; Muddle JR; Gabreëls-Festen AA; Thomas PK; Huxley C
J Anat; 2002 Apr; 200(4):377-90. PubMed ID: 12090404
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Myelin-Specific Gene Expression: Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Oct; 883(1):91-108. PubMed ID: 29086995
[TBL] [Abstract][Full Text] [Related]
36. Tetraspan myelin protein PMP22 and demyelinating peripheral neuropathies: new facts and hypotheses.
Müller HW
Glia; 2000 Jan; 29(2):182-5. PubMed ID: 10625337
[TBL] [Abstract][Full Text] [Related]
37. Peripheral myelin protein 22 gene duplication with atypical presentations: a new example of the wide spectrum of Charcot-Marie-Tooth 1A disease.
Mathis S; Corcia P; Tazir M; Camu W; Magdelaine C; Latour P; Biberon J; Guennoc AM; Richard L; Magy L; Funalot B; Vallat JM
Neuromuscul Disord; 2014 Jun; 24(6):524-8. PubMed ID: 24792522
[TBL] [Abstract][Full Text] [Related]
38. Modeling the Pathogenesis of Charcot-Marie-Tooth Disease Type 1A Using Patient-Specific iPSCs.
Shi L; Huang L; He R; Huang W; Wang H; Lai X; Zou Z; Sun J; Ke Q; Zheng M; Lu X; Pei Z; Su H; Xiang AP; Li W; Yao X
Stem Cell Reports; 2018 Jan; 10(1):120-133. PubMed ID: 29276154
[TBL] [Abstract][Full Text] [Related]
39. Alterations in degradative pathways and protein aggregation in a neuropathy model based on PMP22 overexpression.
Fortun J; Go JC; Li J; Amici SA; Dunn WA; Notterpek L
Neurobiol Dis; 2006 Apr; 22(1):153-64. PubMed ID: 16326107
[TBL] [Abstract][Full Text] [Related]
40. P2X7-mediated increased intracellular calcium causes functional derangement in Schwann cells from rats with CMT1A neuropathy.
Nobbio L; Sturla L; Fiorese F; Usai C; Basile G; Moreschi I; Benvenuto F; Zocchi E; De Flora A; Schenone A; Bruzzone S
J Biol Chem; 2009 Aug; 284(34):23146-58. PubMed ID: 19546221
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
